GERN Q1 2019 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$57,000-82.1% YoY

Gross Profit

-$4M-7077.2% margin

Operating Income

-$11M-19826.3% margin

Net Income

-$10M-17647.4% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

-84.8%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$176M

Total Liabilities

$6M

Stockholders' Equity

$169M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$57,000	$318,000	-82.1%
Gross Profit	-$4M	-$2M	-157.1%
Operating Income	-$11M	-$7M	-52.0%
Net Income	-$10M	-$7M	-40.0%